MHC class II-dependent abnormal reactivity toward bacterial superantigens in immune cells of NOD mice

Diabetes

Volumn 46, Issue 3, 1997, Pages 379-385

  Radons, J ^a,b   Burkart, V ^a   Kolb, H ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STAPHYLOCOCCUS ENTEROTOXIN B;

ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; ETIOLOGY; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; STAPHYLOCOCCUS AUREUS; TOXIC SHOCK SYNDROME;

EID: 0031047741     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.3.379     Document Type: Article

References (65)

1. Marrack P, Kappler J: The staphylococcal enterotoxins and their relatives. Science 248:705-711, 1990
2. Miethke T, Wahl C, Heeg K, Wagner H: Superantigens: the paradox of T-cell activation versus inactivation. Int Arch Allergy Immunol 106:3-7, 1995
3. Kotzin BL, Leung DYM, Kappler J, Marrack P: Superantigens and their potential role in human disease. Adv Immunol 54:99-166, 1993
4. Herman A, Kappler JW, Marrack P, Pullen AM: Superantigens: mechanism of T-cell stimulation and role in immune response. Annu Rev Immunol 9:745-772, 1991
5. Bergdoll MS: Enterotoxins. In Microbial Toxins. III. Bacterial Protein Toxins. Moutie TC, Kadis S, Ajl SJ, Eds. New York, Academic, 1970, p. 265-326
6. Bergdoll MS: Staphylococcal intoxications. In Food Borne Infections and Intoxications. Riemann H, Bryan FL, Eds. New York, Academic Press, 1979, p. 443-494
7. Todd JK, Fishaut M, Kapral F, Welch T: Toxic shock syndrome associated with phage-group I staphylococci. Lancet ii:1116-1118, 1978
8. Taylor JE, Ross DA, Goodacre JA: Group A streptococcal antigens and super-antigens in the pathogenesis of autoimmune arthritis. Eur J Clin Invest 24:511-521, 1994
9. Schiffenbauer J, Johnson HM, Butfiloski EJ, Wegrzyn L, Soos JM: Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis. Proc Natl Acad Sci USA 90:8543-8546, 1993
10. Valdimarsson H, Baker BS, J, Butfiloski EJ, Wegrzyn L, Soos JM: Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis. Immunol Today 16:145-149, 1995
11. Conrad B, Trucco M: Superantigens as etiopathogenetic factors in the development of insulin-dependent diabetes mellitus. Diabetes Metab Rev 10:309-338, 1994
12. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348-2357, 1986
13. Cherwinski HM, Schumacher JH, Brown KD, Mosmann TR: Two types of mouse helper T cell clone. J Exp Med 166:1229-1244, 1987
14. Bottomly K, Luqman M, Greenbaum L, Carding S, West J, Pasqualini T, Murphy DB: A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines. Eur J Immunol 19:617-623, 1989
15. Kelso A: Th1 and Th2 subsets: paradigms lost? Immunol Today 16:374-379, 1995
16. Mosmann TR, Coffman RL: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173, 1989
17. Gajewski TF, Schell SR, Nau G, Fitch FW: Regulation of T-cell activation: differences among T-cell subsets. Immunol Rev 111:79-110, 1989
18. + T-cell subsets in vivo. Immunol Rev 123:189-207, 1991
19. + T cells. Immunol Rev 123:209-229, 1991
20. Romagnani S: Lymphokine production by human T cells in disease states. Annu Rev Immunol 12:227-257, 1994
21. + T cells. Res Immunol 142:14-18, 1991
22. + T cell subset with an unrestricted cytokine profile. J Immunol 143:518-525, 1989
23. Street NE, Schumacher JH, Fong TA, Bass H, Fiorentino DF, Leverah JA, Mosmann TR: Heterogeneity of mouse helper T cells: evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells. J Immunol 144:1629-1639, 1990
24. Campbell IL, Kay TWH, Oxbrow L, Harrison LC: Essential role for Interferon-and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest 87:739-742, 1991
25. Kaufman DL, Clare-Salzier M, Tian J, Forsthuber T, Ting GSP, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV: Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69-72, 1993
26. Shehadeh NN, LaRosa F, Lafferty KJ: Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun 6:291-300, 1993
27. Anderson JT, Cornelius JG, Jarpe J, Winter WE, Peck AB: Insulin-dependent diabetes in the NOD mouse model. II. β cell destruction in autoimmune diabetes is a TH2 and not a TH1 mediated event. Autoimmunity 15:113-122, 1993
28. Shieh DC, Jarpe AJ, Winter WE, Peck AB: Insulin-dependent diabetes in the NOD mouse model. I. Detection and characterization of autoantibody bound to the surface of pancreatic beta cells prior to the development of the insulitis lesion in the prediabetic NOD mouse. Autoimmunity 15:123-135, 1993
29. Rothe H, Faust A, Schade U, Kleemann R, Bosse G, Hibino T, Martin S, Kolb H: Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia 37:1154-1158, 1994
30. Conrad B, Weidman E, Trucco G, Rudert WA, Behboo R, Ricordi C, Rodriguez-Rilo H, Finegold D, Trucco M: Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 371:351-355, 1994
31. + suppressor T cells in superantigen-treated non-obese diabetic mice. J Immunol 151:4362-4370, 1993
32. McDuffie M, Ostrowska A: Superantigen-like effects and incidence of diabetes in NOD mice. Diabetes 42:1094-1098, 1993
33. Ellerman KE, Like AA: Staphylococcal enterotoxin-activated spleen cells passively transfer diabetes in BB/Wor rat. Diabetes 41:527-532, 1992
34. Burkart V, Zielasek J, Kantwerk-Funke G, Hibbe T, Schwab E, Kolb H: Low dose streptozotocin induced diabetes in mice: reduced IL-2 production and modulation of streptozotocin induced hyperglycaemia by IL-2. Int J Immuno-pharmac 14:1037-1044, 1992
35. Mosmann TR, Fong TAT: Specific assays for cytokine production by T cells. J Immunol Methods 116:151-158, 1989
36. Mosmann TR: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63, 1983
37. Denizot F, Lang R: Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89:271-277, 1986
38. Robinson JH, Pyle G, Kehoe MA: Influence of major histocompatibility complex haplotype on the mitogenic response of T cells to Staphylococcal enterotoxin B. Infect Immun 59:3667-3672, 1991
39. Yagi J, Baron J, Buxser S, Janeway CAJ: Bacterial proteins that mediate the association of a defined subset of T cell receptor: CD4 complexes with class II MHC. J Immunol 144:892-901, 1990
40. Hattori M, Buse JB, Jackson RA, Glimcher L, Dorf ME, Minami M, Makino S, Moriwaki K, Kuzuya H, Imura H, Strauss WM, Seidman JG, Eisenbarth GS: The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science 231:733-735, 1986
41. Prochazka M, Serreze DV, Frankel WN, Leiter EH: NOR/Lt mice: MHC-matehed diabetes-resistant control strain for NOD mice. Diabetes 41:98-106, 1992
42. Acha-Orbea H, McDevitt HO: The first external domain of the nonobese diabetic mouse class II I-A β chain is unique. Proc Natl Acad Sci USA 84:2435-2439, 1987
43. Leiter EH, Christianson GJ, Serreze DV, Ting AT, Worthen SI: MHC antigen induction by Interferon γ on cultured mouse pancreatic β cells and macrophages. J Exp Med 170:1243-1262, 1989
44. Ikegami H, Makino S, Harado M, Eisenbarth GS, Hattori M: The cataract Shionogi mouse, a sister strain of the non-obese diabetic mouse: similar class II but different class I gene products. Diabetolagia 31:254-258, 1988
45. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y: Breeding of a non-obese, diabetic strain of mice. Exp Anim 29:1-13, 1980
46. Berschick P, Fehsel K, Weltzien H-U, Kolb H: Molecular analysis of the T-cell receptor Vβ5 and Vβ8 repertoire in pancreatic lesions of autoimmune diabetic NOD mice. J Autoimmun 6:405-422, 1993
47. Nakano N, Kikutani H, Nishimoto H, Kishimoto T: T cell receptor V gene usage of islet β cell-reactive T cells is not restricted in non-obese diabetic mice. J Exp Med 173:1091-1097, 1991
48. O'Reilly LA, Hutchings PR, Cracker PR, Simpson E, Lund T, Kioussis D, Takei F, Baird J, Cooke A: Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression. Eur J Immunol 21:1171-1180, 1991
49. β8 T-lymphocyte-receptor monoclonal antibody therapy in NOD/Wehi mice. Diabetes 38:1492-1495, 1989
50. Zipris D, Crow A, Delovitch TL: Altered thymic and peripheral T-lymphocyte repertoire preceding onset of diabetes in NOD mice. Diabetes 40:429-435, 1991
51. Jun S, Yoon J-W: Prevention of autoimmune IDDM in NOD mice by selective cytokine gene expression induced by superantigens in lymphocytes infiltrating the pancreatic islet (Abstract). Diabetes 45:218A, 1996
52. Soos JM, Russel JK, Jarpe MA, Pontzer CH, Johnson HM: Identification of binding domains on the superantigen, toxic shock syndrome toxin-1, for class II MHC molecules. Biochem Biophys Res Commun 191:1211-1217, 1993
53. Fraser JD: High-affinity binding of staphylococcal enterotoxins A and N to HLA-DR. Nature 339:221-223, 1989
54. Scholl PR, Diez A, Geha RS: Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules. J Immunol 143:2583-2588, 1989
55. Fischer H, Dohlsten M, Lindvall M, Sjörgen H-O, Carlsson R: Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines. J Immunol 142:3151-3157, 1989
56. Webb SR, Gascoigne NRJ: T-cell activation by superantigens. Curr Opinion Immunol 6:467-475, 1994
57. Zhao YX, Abdelnour A, Ljungdahl A, Olsson T, Tarkowski A: Pattern of interferon-γ mRNA expression in toxic shock syndrome toxin-1 expanded V beta 11+ T lymphocytes. Cell Immunol 161:28-33, 1995
58. Sriskandan S, Evans TJ, Cohen J: Bacterial superantigen-induced human lymphocyte responses are nitric oxide dependent and mediated by IL-12 and IFN-γ. J Immunol 156:2430-2435, 1996
59. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC, Power RF: IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J Immunol 154:4874-4882, 1995
60. Ridge JP, Fuchs EJ, Matzinger P: Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271:1723-1726, 1996
61. Rabinovitch A, Sorensen O, Suarez-Pinzon WL, Power RF, Rajotte RV, Bleackley RC: Analysis of cytokine mRNA expression in syngeneic islet grafts of NOD mice: interleukin 2 and interferon γ mRNA expression correlate with graft rejection and interleukin 10 with graft survival. Diabetologia 37:833-837, 1994
62. Rabinovitch A: Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Diabetes 43:613-621, 1994
63. Tompkins SM, Moore JC, Jensen PE: An insulin peptide that binds an alternative site in class II major histocompatibility complex. J Exp Med 183:857-866, 1996
64. Sellins KS, Gold DP, Bellgrau D: Resistance to tolerance induction in the diabetes-prone Biobreeding rat as one manifestation of abnormal responses to superantigens. Diabetologia 39:28-36, 1996
65. Daniel D, Gill RG, Schloot N, Wegman D: Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol 25:1056-1062, 1995